Actions

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
3
Neutral
9
Bullish
2
Bearish
3
Neutral
33
Bullish
10
Bearish
0
Neutral
24
Bullish
8
Bearish
3
Neutral
9
Bullish
2
Bearish
3
Neutral
9
Bullish
2
Bearish
0
Neutral
24
Bullish
8
Bearish
0
Neutral
24
Bullish
8
Bearish
0
Neutral
24
Bullish
8
Personal Products
Personal Care
23 Cr
Low Risk
227.0
41.1
5.5
2.0
37.50
20.08
Sales CAGR
Profit CAGR
ROE
ROCE
Novateor Research Laboratories Ltd (NOVATEOR) is currently trading at 37.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Novateor Research Laboratories Limited develops innovative personal care products with a focus on novel solutions. It has a well-equipped manufacturing facility in Ahmedabad, utilizing semi-automation for efficiency. The company offers unique Tooth Whitening products under the brand 'SmiloShine', marking a pioneering entry in India's market with FDCA approval. Novateor is looking to diversify into cosmetics, healthcare pharma products, and specialty pharmaceuticals, indicating significant expansion plans. The company was publicly listed in 2019, raising Rs 4.49 Crore via IPO, which marks its initial step towards capital market exposure.
Over the past 52 weeks, Novateor Research Laboratories Ltd has traded between a low of ₹20.08 and a high of ₹37.50. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Novateor Research Laboratories Ltd has a market capitalization of approximately 22.70. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Novateor Research Laboratories Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 227.00 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 22.70 Cr, Novateor Research Laboratories Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Novateor Research Laboratories Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Novateor Research Laboratories Ltd is 227.00. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.